Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines

被引:0
|
作者
Li, Hong [2 ]
Zhu, Yi-Fei [1 ]
Zheng, Shi-Ying [1 ]
Jiang, Dong [1 ]
机构
[1] Suzhou Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Suzhou 215006, Jiangsu Prov, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Dept Geriatr, Suzhou 215006, Jiangsu Prov, Peoples R China
关键词
Lung cancer; Multi-drug resistance protein(MRP); Methylation Multi-drug resistance(MDR); CPG HYPERMETHYLATION; PROSTATE-CANCER; PROMOTER REGION; GENE; ALPHA;
D O I
10.1109/FBIE.2009.5405779
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Objective: To study the relationship between the methylation status of multi-drug resistance protein (MRP) gene and the expression of its mRNA and protein in lung cancer cell lines. Methods:Human lung cell line WI-38.lung adenocarcinoma cell line SPCA-1 and its drug-resistant cells induced by different concentrations of doxorubicin were treated with restriction endonuclease Eco47III.The methylation status of MRP was examined by PCR,and the expressions of its mRNA and protein were evaluated by in situ hybridization and immunohistochemistry. Resuits: MRP gene promoter region of WI-38 cells was in hypermethylation status.but the promoter region of MRP in SPCA-1 cells and their resistant derivatives induced by different concentrations of doxorubicin were in hypomethylation status.There were Significant differences in the expression of MRP mRNA among WI-38 cell line.SPCA-1 cells and their drug-resistan t derivatives induced by different con- centration of doxorubicin.Consistently.MRP immunostaining presented similar significant differences. Conclusion:The promoter region of MRP in SPCA-1 lung adenocarcinoma cells was in hypomethylation status. The hypomethylation status of regulatory region of MRP promoter is an important structural basis that can increase the activity of transcrip-tion and results in the development of drug resistan cc in lung cancer.
引用
收藏
页码:548 / +
页数:2
相关论文
共 50 条
  • [1] Relationship between methylation status of multi-drug resistance protein(MRP) and multi-drug resistance in lung cancer cell lines
    Liu Rui-jun
    Zhong Hong
    CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (04) : 277 - 282
  • [2] Relationship between Methylation Status of Multi-drug Resistance Protein(MRP) and Multi-drug Resistance in Lung Cancer Cell Lines
    柳瑞军
    钟竑
    Chinese Journal of Cancer Research, 2007, (04) : 277 - 282
  • [3] Multi-drug resistance and cancer
    Atalay, Can
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (05) : 511 - 520
  • [4] THE SUPPRESSION OF MULTI-DRUG RESISTANCE IN THE SECONDARY DRUG RESISTANCE CELL LINE OF OVARIAN CANCER
    Park, C. M.
    Kim, S. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 58 - 58
  • [5] Nanoliposomal multi-drug delivery system with reduced toxicity and multi-drug resistance
    Jing Yang
    Chiyu Wen
    Chao Pan
    Hongshuang Guo
    Weiqiang Zhao
    Jiamin Zhang
    Yingnan Zhu
    Yumiao Zhang
    Lei Zhang
    Journal of Materials Science, 2019, 54 : 9718 - 9728
  • [6] Nanoliposomal multi-drug delivery system with reduced toxicity and multi-drug resistance
    Yang, Jing
    Wen, Chiyu
    Pan, Chao
    Guo, Hongshuang
    Zhao, Weiqiang
    Zhang, Jiamin
    Zhu, Yingnan
    Zhang, Yumiao
    Zhang, Lei
    JOURNAL OF MATERIALS SCIENCE, 2019, 54 (13) : 9718 - 9728
  • [7] Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
    Tekchandani, Pawan
    Das Kurmi, Balak
    Paliwal, Shivani Rai
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (18) : 1793 - 1810
  • [8] IS THE CANCER STEM CELL POPULATION "A PLAYER" IN MULTI-DRUG RESISTANCE?
    Drewa, Tomasz
    Styczynski, Jan
    Szczepanek, Joanna
    ACTA POLONIAE PHARMACEUTICA, 2008, 65 (04): : 493 - 500
  • [9] tRNA Methylation Is a Global Determinant of Bacterial Multi-drug Resistance
    Masuda, Isao
    Matsubara, Ryuma
    Christian, Thomas
    Rojas, Enrique R.
    Yadavalli, Srujana S.
    Zhang, Lisheng
    Goulian, Mark
    Foster, Leonard
    Huang, Kerwyn Casey
    Hou, Ya-Ming
    CELL SYSTEMS, 2019, 8 (04) : 302 - +
  • [10] Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)
    Seita Matsunaga
    Takeshi Asano
    Arisa Tsutsuda-Asano
    Yoshitaka Fukunaga
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 348 - 353